High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/8120548

Download in:

View as

General Info

PMID
8120548